Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy Challenge Study of Live Oral Cholera Vaccine Candidate,PXVX0200, to Prevent Cholera

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* healthy men or women,~* age 18 to 45 years inclusive;~* normal medical history and physical examination; and~* no clinically significant abnormalities from:~* urine dipstick for glucose, protein, and blood~* complete blood count,~* serum hepatic transaminases,~* total bilirubin (direct if abnormal),~* creatinine,~* electrolytes,~* albumin, or~* electrocardiogram.~* Women must have a negative pregnancy test.~Exclusion Criteria:~* travel to a cholera endemic area in the previous 5 years;~* abnormal stool pattern or regular use of laxatives;~* history of eating disorders (such as bulimia), anal or rectal disorders, allergy to tetracycline and/or ciprofloxacin;~* history of cholera or enterotoxigenic E. coli challenge or infection;~* current or recent antibiotic use;~* pregnancy or nursing;~* positive serology for HIV, hepatitis B antigen, or hepatitis C;~* any immunosuppressive medical condition;~* history of hospitalization for psychiatric illness or use of specific psychiatric drugs.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- PXVX0200 (Type: EXPERIMENTAL): Biological: PXVX0200 Single dose; liquid suspension after reconstitution with buffer; 5x10\^8 CFU
- Placebo (Type: PLACEBO_COMPARATOR): Biological: Placebo physiological saline

Based on this trial design, predict the completion outcome and termination type (if applicable).